Skip to main content

Table 1 Children involved in this study. Characteristics of included children at last follow-up (FU)

From: Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases

Demographic

ADS n = 27

MS n = 10

ADEM n = 5

ADS MOG+ n = 6

Others n = 6

Sex M/F

6: 21

1: 9

1: 4

2: 4

2: 4

Age years, mean, SD

11.1 ± 4.1

12.8 ± 1.9

7.9 ± 5.5

8.9 ± 4.3

13.1 ± 2.6

EDSS mean, SD

0.7 ± 1.2

1.4 ± 1.6

0 ± 0

0.7 ± 0.8

0 ± 0

CSF

     

Cell > 10 mm3

11

3

2

5

1

Prot >  0.5 g/dL

7

3

1

2

1

OCB (n = 22)

8

6/10

1/3

1/5

0/4

FU years, mean, SD

3.0 ± 1.6

3.5 ± 1.2

3.2 ± 0.9

3.8 ± 2.3

1.3 ± 0.7

Anti-AQP4

0

0

0

0

0

Anti-MOG

12

0

1

6

5

  1. ADS acquired demyelinating syndrome, MS multiple sclerosis, ADEM acute demyelinating encephalomyelitis, ADS MOG+ non-MS relapsing demyelinating diseases with anti-MOG-Abs, Others:optic neuritis (n = 3), transverse myelitis (n = 2), hemiplegia (n = 1). Expanded Disability Status Scale (EDSS), oligo-clonal bands (OCB), follow-up (FU)